SAB Biotherapeutics, Inc.

NASDAQ:SABS

Biotechnology

Healthcare
$2.91 -0.53%

-$0.02 today

Market cap
$262.16M
Beta
0.53
P/E (TTM)
3.0
EPS (TTM)
-$0.16
52W Low $1.85High $5.15

Volume 1.75M

Average 0.76M

Balance Sheet

Inspect the capital base behind the business.

Assets

$172.81M

FY 2025 · Annual

+291.0% YoY

Liabilities

$21.32M

FY 2025 · Annual

+17.0% YoY

Equity

$151.49M

FY 2025 · Annual

+483.4% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents33.21M15.05M56.57M8.9M10.5M
Short-term Investments00011.86M86.09M
Net Receivables8.01M5.56M054.96K946.78K
Inventory00000
Other Current Assets6.34M002.98M3.51M
Total Current Assets50.19M22.1M58.91M23.79M101.05M
Property, Plant & Equipment (Net)30.95M28.34M24.68M19.92M19.4M
Goodwill00000
Intangible Assets00000
Long-term Investments000046.89M
Tax Assets00000
Other Non-current Assets(1)467.69K350.23K482.1K5.46M
Total Non-current Assets30.95M28.81M25.03M20.4M71.76M
Total Assets81.14M50.9M83.94M44.2M172.81M
Account Payables4.46M3.68M945.93K1.69M3.15M
Short-term Debt1.8M772.67K1.05M275.85K951.37K
Tax Payables216.25K50K40K00
Deferred Revenue100K01.32M00
Other Current Liabilities8.7M8.1M4.49M01.55M
Total Current Liabilities26.46M14.99M10.81M7.98M10.68M
Long-term Debt0541.64K000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities10.72M320.93K11.77M6.39M5.64M
Total Non-current Liabilities16.14M4.85M15.83M10.25M10.63M
Total Liabilities42.59M19.85M26.64M18.23M21.32M
Common Stock4.35K5.09K9299354.77K
Retained Earnings(29.13M)(47.87M)(90.06M)(124.17M)(110.9M)
Accumulated OCI0026.42K(135.41K)186.51K
Other Stockholders Equity00000
Minority Interest00000
Total Equity38.55M31.06M57.3M25.97M151.49M
Total Debt8.52M5.93M5.91M4.67M5.95M
Net Debt(24.69M)(9.12M)(50.66M)(4.23M)(4.55M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$8.3M
Short-term Investments$94.4M
Receivables$1.8M
Other Current$3.5M
Total Current Assets$107.9M
PP&E (Net)$19.6M
Long-term Investments$105.3M
Other Non-current$5.3M
Total Non-current Assets$130.3M
Total Assets$238.2M

Analysis

Selected assets total $238.2M for Latest. The largest visible component is Long-term Investments at $105.3M, about 44.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 5, 2026
25-NSE25-NSE filingOct 22, 2026
8-KCurrent reportOct 13, 2026
4Statement of changes in beneficial ownershipSep 18, 2026
424B3424B3 filingAug 21, 2026

How much cash does SABS have?

SAB Biotherapeutics, Inc. (SABS) reported $10.50M in cash and equivalents in fiscal 2025.

How much debt does SABS carry?

SAB Biotherapeutics, Inc. (SABS) reported $5.95M of total debt, with net debt of -$4.55M.